Showing results (11-20 of 204) with videos related to
Sort By:
Pageof 21
Lancet (London, England)|October 12, 1991
Letters to patients: improving communication in cancer careD Damian, M H TattersallAnnals of the Academy of Medicine, Singapore|July 1, 1987
Biochemical modulation of fluorouracil therapy in advanced colorectal cancerJ Mackintosh, M H TattersallAustralian and New Zealand Journal of Medicine|December 1, 1989
Primary cerebral lymphoma: presentation of eight cases and review of the literatureD J Boadle, M H TattersallThe Australian & New Zealand Journal of Obstetrics & Gynaecology|November 1, 1987
Phase II study of mitoxantrone in advanced or metastatic endometrial carcinomaD J Boadle, M H TattersallAnnals of Medicine|November 26, 1999
How should doctors communicate the diagnosis of cancer to patients?P M Ellis, M H TattersallAustralian and New Zealand Journal of Public Health|April 12, 2001
Advocacy for clinical trials: do the Royal Colleges and State cancer councils play an appropriate role?P M Ellis, M H TattersallBritish Journal of Cancer|March 1, 1989
Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transportJ M Hughes, M H TattersallBiochemical Pharmacology|July 15, 1991
Inhibition of 2-desamino-2-methyl-10-propagyl-5,8-dideazafolic acid cytotoxicity by 5,10-dideazatetrahydrofolate in L1210 cells with decrease in DNA fragmentation and deoxyadenosine triphosphate poolsJ B Kwok, M H TattersallBiochemical Pharmacology|March 15, 1995
5,10-Dideazatetrahydrofolic acid reduces toxicity and deoxyadenosine triphosphate pool, expansion in cultured L1210 cells treated with inhibitors of thymidylate synthaseL K Chong, M H TattersallPageof 21